Published in Br Med J on September 13, 1980
Repeat prescribing of non-steroidal anti-inflammatory drugs excluding aspirin: how careful are we? Br Med J (Clin Res Ed) (1987) 1.88
Different interactions of indomethacin and sulindac with thiazides in hypertension. Br Med J (Clin Res Ed) (1982) 1.18
Influence of non-steroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension. Br Med J (Clin Res Ed) (1984) 1.17
The effects of sulindac and indomethacin on the anti-hypertensive and diuretic action of hydrochlorothiazide in patients with mild to moderate essential hypertension. Br J Clin Pharmacol (1986) 0.91
Failure of indomethacin to modify beta-adrenoceptor blockade. Br J Clin Pharmacol (1983) 0.90
Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension. Br J Clin Pharmacol (1982) 0.88
Flurbiprofen interaction with single doses of atenolol and propranolol. Br J Clin Pharmacol (1984) 0.82
Cardiovascular risks and benefits of perioperative nonsteroidal anti-inflammatory drug treatment. Drugs (1992) 0.80
Nifedipine interactions in hypertensive patients. Cardiovasc Drugs Ther (1990) 0.77
The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril. Br J Clin Pharmacol (1989) 0.76
Cardiovascular effects of a chlorpheniramine/paracetamol combination in hypertensive patients who were sensitive to the pressor effect of pseudoephedrine. Br J Clin Pharmacol (1991) 0.76
Comparison of aspirin and indomethacin pre-treatments on the responses to reduced renal artery pressure in conscious dogs. J Physiol (1983) 0.75
Indomethacin does not attenuate the ocular hypotensive effect of timolol. Br J Clin Pharmacol (1985) 0.75
Medication review for older people in general practice. J R Soc Med (1994) 0.75
Interaction of indomethacin and sulindac with labetalol. Br J Clin Pharmacol (1991) 0.75
A study of the potential interactions between azapropazone and frusemide in man. Br J Clin Pharmacol (1984) 0.75
Drug interactions and beta blockers. Br Med J (Clin Res Ed) (1984) 0.75
The effect of tenidap on the anti-hypertensive efficacy of thiazide diuretics in patients treated for mild to moderate hypertension. Br J Clin Pharmacol (1995) 0.75
Resistant hypertension: evaluation of the patient. Can Fam Physician (1983) 0.75
Treatment of hypertension with propranolol. Br Med J (1969) 8.21
The paradox of beta-adrenergic blockade in hypertension. Circulation (1968) 3.78
Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol (1972) 3.37
Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins (1975) 1.98
The effect of chronic adrenergic receptor blockade on plasma renin activity in man. J Clin Endocrinol Metab (1972) 1.75
Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1969) 1.56
The mode of action of aspirin and similar compounds. J Allergy Clin Immunol (1976) 1.52
The effect of indomethacin on kidney function and plasma renin activity in man. Nephron (1976) 1.42
Role of prostaglandins in the pathogenesis of Bartter's syndrome. Am J Med (1976) 1.27
Influence of indomethacin on the systemic and pulmonary vascular resistance in man. Clin Sci Mol Med (1978) 1.12
Modification of antihypertensive effect of beta-adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis. Lancet (1977) 1.09
A high-speed liquid chromatographic analysis of indomethacin in plasma. J Chromatogr (1975) 1.08
Principles of membrane receptor physiology and their application to clinical medicine. Ann Intern Med (1980) 1.05
Mechanism of hypotensive effect during betaadrenergic blockade in hypertensive patients. Am Heart J (1976) 1.02
Quantitative determination of the major metabolite of prostaglandins F1alpha and F2alpha in human urine by stable isotope dilution and combined gas chromatography--mass spectrometry. Biochem Med (1976) 0.99
Effects of propranolol on patients with complete heart block and implanted pacemakers. Circulation (1967) 0.93
Salt in hypertension and the effects of diuretics. Annu Rev Pharmacol Toxicol (1979) 0.92
Prostaglandin A1: antihypertensive and renal effects. Studies in patients with essential hypertension. Ann Intern Med (1971) 0.92
Coverage by the news media of the benefits and risks of medications. N Engl J Med (2000) 7.50
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet (1998) 6.20
Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths). Br J Pharmacol (1971) 6.11
Quetelet's index (W/H2) as a measure of fatness. Int J Obes (1985) 5.74
Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J (1973) 5.65
Monitoring adverse reactions to drugs. Br Med J (1977) 4.41
Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967. Q J Med (1970) 3.71
A symptom questionnaire for hypertensive patients. J Chronic Dis (1974) 3.51
Atenolol and bendrofluazide in hypertension. Br Med J (1975) 3.35
Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet (1968) 3.33
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25
Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13
Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun (1993) 3.04
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Effect of propranolol in mild hypertension. Lancet (1966) 2.57
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Blood concentrations in man of fluorinated hydrocarbons after inhalation of pressurised aerosols. Lancet (1970) 2.48
Prostacyclin is not a circulating hormone in man. Prostaglandins (1982) 2.46
European journals, societies, and meetings. Meetings. Br Med J (1973) 2.46
Incidence of a positive direct coombs test in patients on alpha-methyldopa. Lancet (1966) 2.44
Isolation and enumeration of Listeria monocytogenes from Sewage, Sewage Sludge and River Water. J Appl Bacteriol (1981) 2.42
Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun (1993) 2.36
A method of assessment during vocational training: report of a pilot study. J R Coll Gen Pract (1985) 2.32
Clinical medicine and research in France. Br Med J (1973) 2.32
The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol (1996) 2.29
Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet (1991) 2.27
Computer-based hypertension clinic records: a co-operative study. Br Med J (1974) 2.24
Intravenously administered isoproterenol sulfate dose-response curves in man. Arch Intern Med (1972) 2.23
Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. Lancet (1967) 2.22
Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22
Atenolol once-daily in hypertension. Br J Clin Pharmacol (1977) 2.21
Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J (1976) 2.15
Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J (1976) 2.13
The metabolic fate of DL(7-3H)isoprenaline in man and dog. Biochem J (1969) 2.06
Preventing strokes in non-rheumatic atrial fibrillation. Br J Hosp Med (1994) 2.03
Absorption and metabolism of nicotine from cigarettes. Br Med J (1975) 2.01
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01
I. Ophthalmoscopic and circulatory changes in focal retinal ischaemia. Br J Ophthalmol (1966) 1.99
Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation (2000) 1.98
Pharmacokinetics of indoramin in man. Br J Clin Pharmacol (1976) 1.97
Anaphylactoid reactions to i.v. substances. Br J Anaesth (1979) 1.93
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93
Suxamethonium anaphylaxis. Lancet (1989) 1.93
Clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1970) 1.92
Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther (1977) 1.91
The effects of indomethacin on arachidonic acid and prostaglandins e2 and f2alpha levels in human skin 24 h after u.v.B and u.v.C irradiation. Br J Clin Pharmacol (1978) 1.89
The effect of systemic prednisolone on arachidonic acid, and prostaglandin E2 and F2 alpha levels in human cutaneous inflammation. Br J Clin Pharmacol (1982) 1.87
Influence of arm position on measurement of blood pressure. Br Med J (Clin Res Ed) (1984) 1.86
Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol (1973) 1.85
Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol (1975) 1.79
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension. Br Med J (1980) 1.78
Clinical evaluation of indoramin, a new antihypertensive agent. Eur J Clin Pharmacol (1973) 1.78
Minoxidil in resistant hypertension. Lancet (1977) 1.77
Identification and quantitation of hypersensitivity reactions to intravenous anaesthetic agents. Br J Anaesth (1976) 1.76
Cytochrome composition and effect of catalase on growth of Agromyces ramnosus. Nature (1970) 1.75
The drug treatment of hypertension. Practitioner (1971) 1.75
Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet (1982) 1.73
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72
Bench and ambulatory field evaluation of the A & D TM-2420 automated sphygmomanometer. J Hypertens (1990) 1.71
Role of nifedipine in treatment of hypertension. Br Med J (Clin Res Ed) (1983) 1.70
A new method of obtaining human skin inflammatory exudate for pharmacological analysis [proceedings]. Br J Pharmacol (1976) 1.70
Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol (1989) 1.68
Dopamine agonists and pituitary tumor shrinkage. Endocr Rev (1992) 1.67
Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet (1989) 1.66
Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis (1986) 1.65
Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet (1966) 1.61
Medical students in general practice: how do patients feel? Br J Gen Pract (1996) 1.59
Hydrallazine-induced cutaneous vasculitis. Br Med J (1980) 1.59
A new method for recovery of exudates from normal and inflamed human skin. Clin Exp Dermatol (1977) 1.58
Computer assisted shared care in hypertension. Br Med J (Clin Res Ed) (1985) 1.57
Editorial: Pharmacokinetics--master or servant? Eur J Clin Pharmacol (1973) 1.57
Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther (1975) 1.56
Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1969) 1.56
Immune-mediated reactions to althesin (alphaxalone). Br J Anaesth (1976) 1.56
Radiology report times: impact of picture archiving and communication systems. AJR Am J Roentgenol (1998) 1.55
Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables. J Neurol Neurosurg Psychiatry (2003) 1.53
Alveolar gas concentrations of fluorocarbons-11 and-12 in man after use of pressurized aerosols. Thorax (1974) 1.52
Health state utilities for metastatic breast cancer. Br J Cancer (2006) 1.50
The nutritional management of acute diarrhea in young infants: effect of carbohydrate ingested. J Pediatr Gastroenterol Nutr (1994) 1.50
Heparin kinetics in venous thrombosis and pulmonary embolism. Circulation (1976) 1.50
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. Br Heart J (1980) 1.49
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins (1979) 1.48
Adverse reactions to intravenous anaesthetic induction agents. Br Med J (1977) 1.47
Increased pulmonary alpha-adrenergic and reduced beta-adrenergic receptors in experimental asthma. Nature (1980) 1.46
Effect of enalapril on the skin response to bradykinin in man. Br J Clin Pharmacol (1987) 1.46
Measurement of plasma histamine in asthma. Clin Allergy (1983) 1.46
Central hypotensive effect of propranolol in the rabbit. Br J Pharmacol (1973) 1.44
Surgical treatment of emphysema. Br Med J (1966) 1.44
Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP) J Hum Hypertens (2000) 1.44
The importance of central adrenergic neurones in renal hypertension in rabbits. J Physiol (1974) 1.43
Prostacyclin deficiency in haemolytic-uraemic syndrome. Br Med J (1980) 1.43
Increased prostaglandins E2 and F2alpha in human skin at 6 and 24 h after ultraviolet B irradiation (290- 320 nm). Br J Clin Pharmacol (1978) 1.43
Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet (1981) 1.42
A quality-of-care analysis of cascade iatrogenesis in frail elderly hospital patients. QRB Qual Rev Bull (1993) 1.42